CP-92

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCP-92
Drug Alias Nameanti-inflammatory compound (Cryptopharma)CP-92
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCryptopharma Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCryptopharma Pty Ltd
Active IndicationsN/A
Inactive IndicationsCystic Fibrosis

Other Information

ATC CodeN/A
Related LinksN/A